Thermo Fisher ScientificRegister for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Thermo Fisher ScientificLife-science tools group whose Patheon pharma services arm runs what the company calls the largest sterile fill-finish CDMO network. Acquired Sanofi's Ridgefield, NJ sterile fill-finish site in September 2025 and is investing about $1B across 60 CDMO sites in 2026, adding prefilled syringe, cartridge, and autoinjector assembly lines.
Browse all official SEC filings including annual reports, quarterly updates, and material event disclosures.
SEC filings for this company are not available at the moment.